טוען...
Down-regulation of CD40 signal and induction of TGF-β by Phosphatidylinositol mediates reduction in immunogenicity against recombinant human Factor VIII
Factor VIII (FVIII) is an important coagulation cofactor and its deficiency causes Hemophilia A, a bleeding disorder. Replacement therapy using recombinant FVIII is currently the first line of therapy for Hemophilia A, but the development of neutralizing antibody is a major clinical complication for...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3996553/ https://ncbi.nlm.nih.gov/pubmed/21953409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jps.22746 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|